Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2021 Annual Meeting | Headache Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Headache
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
Messoud Ashina, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 002 - Long-term Use of Rimegepant 75 mg for the Acute Treatment of Migraine Reduces Use of Analgesics and Antiemetics
David B. Kudrow, MD
07:00 AM - 05:00 PM EDT Abstract 003 - Randomized, Controlled Trial of Lasmiditan over Four Migraine Attacks: Consistency Findings
Judith Krikke
07:00 AM - 05:00 PM EDT Abstract 004 - Long-Term Safety of Rimegepant 75 mg for the Acute Treatment of Migraine in Adults With a History of Triptan Treatment Failure
Kathleen B. Mullin, MD
07:00 AM - 05:00 PM EDT Abstract 005 - Consistency of Effect with Galcanezumab Across Multiple Cluster Periods in Episodic Cluster Headache
Brian Maxwell Plato, DO
07:00 AM - 05:00 PM EDT Abstract 006 - Acute Treatment with Rimegepant 75 mg Confers Long Term Improvements in Median Time to 30% and 50% Reductions in Monthly Migraine Days – Post Hoc Results from an Open Label Safety Study (BHVN-3000-201)
Gilbert J. L'Italien
07:00 AM - 05:00 PM EDT Abstract 007 - Efficacy in Patients Switching from Quarterly to Monthly Fremanezumab or Maintained on Monthly Fremanezumab Treatment Over 6 Months in the Phase 3b FOCUS Study
Jonathan P. Gladstone, MD
07:00 AM - 05:00 PM EDT Abstract 008 - Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results from a Long-Term Open-Label Safety Study
Jack D. Schim, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 009 - Randomized, Controlled Trial of Lasmiditan over Four Migraine Attacks: First Attack Findings
Timothy *USE ID 123628 Smith
07:00 AM - 05:00 PM EDT Abstract 010 - Pharmacokinetics, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine Following Coadministration With Preventive Monoclonal Antibody Treatment
Janette Contreras-De Lama
07:00 AM - 05:00 PM EDT Abstract 011 - Real-World Evidence for Control of Patients With Chronic Migraine Who Received Calcitonin Gene?Related Peptide (CGRP) Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment
Andrew M. Blumenfeld, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 012 - Real-World Evidence for Control of Chronic Migraine (CM) in Patients Meeting American Headache Society (AHS) Criteria Who Received Calcitonin Gene?Related Peptide Monoclonal Antibody (CGRPmAb) Therapy Added to OnabotulinumtoxinA Treatment
Andrew M. Blumenfeld, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 013 - A long-term, open label Safety and Tolerability Study Of Precision Olfactory Delivery of DHE in Acute Migraine Treatment (STOP 301): Exploratory Efficacy Results
Sheena K. Aurora, MD
07:00 AM - 05:00 PM EDT Abstract 014 - Rimegepant 75 mg for the Acute Treatment of Migraine in Adults With Frequent Migraine: Long-Term Safety and Clinical Improvement Versus Baseline
Kathleen B. Mullin, MD
07:00 AM - 05:00 PM EDT Abstract 015 - Intranasal Ketamine as a Promising Acute Treatment for Refractory Headache
Jade Suehyun Park, MD
07:00 AM - 05:00 PM EDT Abstract 016 - Rimegepant for the Acute Treatment of Migraine in Patients with a History of Triptan Treatment Failure: Pooled Results From 3 Phase 3 Clinical Trials
Christopher Jensen, PharmD
07:00 AM - 05:00 PM EDT Abstract 017 - Acute Treatment with Rimegepant 75 mg Confers Clinically Relevant Improvement in Lost Time (Days) Due to Migraine: Results From a 1-Year, Open-Label Safety Study (BHV3000-201)
Gilbert J. L'Italien
07:00 AM - 05:00 PM EDT Abstract 018 - A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Robert Croop, MD
07:00 AM - 05:00 PM EDT Abstract 019 - Relation between intervals of the menstrual cycle and presentation to the Emergency Department for headache
Crystal Jicha, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Does Wearing Off of Efficacy Occur in Galcanezumab-Treated Patients at the End of the Monthly Treatment Cycle: A Post Hoc Analysis of Four Phase 3 Randomized Trials
Jessica Ailani, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 021 - Early Reductions in Headache Severity and Duration With Fremanezumab Treatment in the Randomized, Double-blind Phase 3b FOCUS study
Messoud Ashina, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 022 - Eptinezumab Treatment Initiated During a Migraine Attack Prolonged the Time to Next Migraine and Improved HIT-6 Outcomes in the RELIEF Study
Peter J. McAllister, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 023 - Long-term Efficacy of Fremanezumab in Patients With Chronic or Episodic Migraine Who Were Inadequate Responders to Initial Fremanezumab Treatment
Stephen D. Silberstein, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 024 - Efficacy of Fremanezumab in Patients With Lower and Higher Frequency Chronic Migraine
Peter J. McAllister, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 025 - Interictal Burden of Migraine: Correlations with Other Measures of Migraine Burden and Effects of Galcanezumab Migraine-Preventive Treatment
Claire Haist Sandoe, MD
07:00 AM - 05:00 PM EDT Abstract 026 - Atogepant Improved Patient-Reported Outcome (PRO) Measures of Activity Impairment in Migraine-Diary and Headache Impact Test in a 12-Week, Double-blind, Randomized Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine
Richard B. Lipton, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 027 - Impact of Fremanezumab on Disability Severity in Patients With Episodic and Chronic Migraine: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
Abraham J. Nagy, MD
07:00 AM - 05:00 PM EDT Abstract 028 - Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Adolescents
Andrew D. Hershey, MD, PhD, FAHS, FAAN
07:00 AM - 05:00 PM EDT Abstract 029 - A Phase 2 Study of Fremanezumab as a Treatment for Posttraumatic Headache in Adult Patients
Egilius L H Spierings, MD,PhD
07:00 AM - 05:00 PM EDT Abstract 030 - Remote Electrical Neuromodulation for the Acute Treatment of Chronic Migraine
Brian Grosberg, MD
07:00 AM - 05:00 PM EDT Abstract 031 - US Real-world Effectiveness of Quarterly and Monthly Fremanezumab for Reducing Migraine Days and Headache Days in Adult Patients With Migraine
Joshua M. Cohen, MD
07:00 AM - 05:00 PM EDT Abstract 032 - Comparative Effectiveness of Erenumab versus Oral Preventive Medications among Migraine Patients: A US Claims Database Study
Stewart J. Tepper, MD
07:00 AM - 05:00 PM EDT Abstract 033 - Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
Paul Winner, DO, FAAN
07:00 AM - 05:00 PM EDT Abstract 034 - Cardiovascular Safety of Fremanezumab in Patients With Migraine and Cardiovascular Medical History or Risk Factors: A Pooled Analysis of Phase 3 Studies
Stephanie J. Nahas, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 035 - Healthcare utilization in patients with acute migraine: pre- and post-treatment with INP104 in a phase 3 study
Carrie Dougherty, MD
07:00 AM - 05:00 PM EDT Abstract 036 - Atogepant Improved Patient-Reported Migraine-Specific Quality of Life in a 12-Week Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine
David W. Dodick, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 037 - Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the CENTURION Study
Uwe Reuter
07:00 AM - 05:00 PM EDT Abstract 038 - Cardiovascular Safety Results of INP104 (POD-DHE) from the STOP 301 Phase 3 Study
Karen Craig
07:00 AM - 05:00 PM EDT Abstract 039 - Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data from a Phase 3 Clinical Trial (ADVANCE) in Patients with Episodic Migraine
Pranav Gandhi
07:00 AM - 05:00 PM EDT Abstract 040 - Safety and Tolerability of Ubrogepant Within Various Demographic and Clinical Characteristic Subgroups
Jessica Ailani, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 041 - Real-World Safety and Efficacy of 155-195U OnabotulinumtoxinA in Participants With Chronic Migraine: Results From the REPOSE Study
Katherine Sommer
07:00 AM - 05:00 PM EDT Abstract 042 - A Phase 1, Open-Label, Single-Dose Pharmacokinetic Study of Lasmiditan in Paediatric Patients with Migraine
M Tsai
07:00 AM - 05:00 PM EDT Abstract 043 - Comparison of Efficacy Outcomes in Trials Using a M207 in the Acute Treatment of a Single Migraine or Multiple Migraines
Donald Kellerman
07:00 AM - 05:00 PM EDT Abstract 044 - Risk of Hypertension in Erenumab-treated Patients With Migraine in Clinical Trials and in the Postmarketing Setting
David W. Dodick, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 045 - Tolerability of Lasmiditan in Elderly Patients with Migraine
Zubair Ahmed, MD
07:00 AM - 05:00 PM EDT Abstract 046 - Efficacy of Fremanezumab in Patients With Moderate and Higher Frequency Episodic Migraine
Stephanie J. Nahas, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 047 - Design and Population characteristics of patients treated with monoclonal antibody erenumab for assessment of long-term safety and tolerability and frequency of drug holidays in Germany (APOLLON)
Sonja Ortler, MD
07:00 AM - 05:00 PM EDT Abstract 049 - Characterizing Preventive Treatment Gaps in Migraine: Results from the CaMEO Study
Stephanie J. Nahas, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 050 - Optimized Acute Treatment Is Associated With Productivity Gains in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Dawn C. Buse, PhD
07:00 AM - 05:00 PM EDT Abstract 051 - US Real-world Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab
Michael Seminerio
07:00 AM - 05:00 PM EDT Abstract 052 - Services for Headache Disorder(s) among Men and Women Veterans across the Veterans Health Administration – a 10-year Cohort Study
Elizabeth Seng, PhD
07:00 AM - 05:00 PM EDT Abstract 053 - Headache and Pain Multimorbidity in a National Cohort of U.S. Veterans with Cluster Headache
Jason J. Sico, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 054 - Use of predictive modeling to determine treatment-response to OTC Medications in Acute Migraine: Results from the American Migraine Prevalence and Prevention Study (AMPP)
Ali Ezzati, MD
07:00 AM - 05:00 PM EDT Abstract 055 - Migraine Patients Exhibit Increased Risk Of Developing Chronic Migraine With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis
Ali Mohajer, PhD
07:00 AM - 05:00 PM EDT Abstract 056 - Seeking Care, Diagnosis, and Acute Prescription for Migraine Among Those with Headache-Related Disability: Results of the OVERCOME Study
Susan Hutchinson
07:00 AM - 05:00 PM EDT Abstract 057 - Static and Dynamic Functional Connectivity Differences in Migraine compared to Healthy Controls
Catherine Daniela Chong, PhD, FAAN
07:00 AM - 05:00 PM EDT Abstract 058 - DAGLa Inhibition as a Non-invasive and Translational Model of Episodic Headache
Aidan Levine
07:00 AM - 05:00 PM EDT Abstract 059 - Eptinezumab:CGRP Complex Structure and Characterization of the Ligand Binding Interface
Kira Misura
07:00 AM - 05:00 PM EDT Abstract 060 - Disease-Specific Validation of the revised Utah Photophobia Symptom Impact Scale in Migraine Subjects
Alexander Knudson
07:00 AM - 05:00 PM EDT Abstract 061 - Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study
Roberta Messina, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 062 - Altered Functional Network Connectivity in Chronic Migraine: a Replication-Extension Study
Danielle D. DeSouza, PhD
07:00 AM - 05:00 PM EDT Abstract 063 - Novel Receptor Activity Mapping of Methysergide and its Metabolite, Methylergometrine, Provides a Mechanistic Rationale for both the Clinically Observed Efficacy and Risk of Fibrosis in Patients with Migraine
Scott Borland
07:00 AM - 05:00 PM EDT Abstract 064 - Mass Balance and Metabolism of Carbon-14 Atogepant in Healthy Male Participants
Josh Rowe
07:00 AM - 05:00 PM EDT Abstract 065 - DHE Pharmacology Revisited: Does a broad receptor profile molecule treat the whole migraine?
Sheena K. Aurora, MD
07:00 AM - 05:00 PM EDT Abstract 066 - Exercised Brain in Pain: Quantification of Exercise in Migraine Patients Seen at a Large Tertiary Headache Center
Mason Daniel Dyess, DO
07:00 AM - 05:00 PM EDT Abstract 067 - Medication Overuse Headache in Chronic Migraine Patients Using Cannabis: A Case-Referent Study
Niushen Zhang, MD
07:00 AM - 05:00 PM EDT Abstract 068 - Survivors of Military Sexual Trauma face increased risk of Migraine Headaches and Worse Headache Care
John Ney, MD, MPH, FAAN
07:00 AM - 05:00 PM EDT Abstract 069 - Joint Hypermobility Syndrome in Children and Adolescents with Headache: a retrospective study
Ankita Ghosh, MD
07:00 AM - 05:00 PM EDT Abstract 070 - Migrainous Infarction: Case series in a neurological center of Buenos Aires
Florencia Wainberg, MD
07:00 AM - 05:00 PM EDT Abstract 071 - Tardive Dyskinesia in Migraine
Wojciech Gryc, MD
07:00 AM - 05:00 PM EDT Abstract 072 - Association of migraine with hospitalization for mental health disorders in US adults
Liqi Shu, MD
07:00 AM - 05:00 PM EDT Abstract 073 - Impact of Remote Learning in Children with Primary Headache Syndromes
Theodora Andriotis, DO
07:00 AM - 05:00 PM EDT Abstract 074 - Increased Prevalence of Headache in Patients with Sensory Neuropathic Symptoms
Hsinlin T. Cheng, MD
07:00 AM - 05:00 PM EDT Abstract 075 - Air pollution, methane super-emitters, and oil and gas wells in Northern California: the relationship with migraine headache prevalence and exacerbation
Holly Elser, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 076 - Clinical Manifestations of Stroke in Migraineurs
Merrill Maguire Brady Moe, MD
07:00 AM - 05:00 PM EDT Abstract 077 - Headache during SARS-CoV-2 infection as an early symptom associated with mild inflammation and pulmonary disease: a retrospective cohort study
Alicia Gonzalez-Martinez, MD
07:00 AM - 05:00 PM EDT Abstract 078 - Headache associated with personal protective equipment in healthcare workers during COVID-19 outbreak in a referral centre in Mexico
Rogelio Dominguez-Moreno, MD
07:00 AM - 05:00 PM EDT Abstract 079 - MRI findings in Neurosarcoidosis Patients with Headache as a Primary Presenting Symptom
Yamin Sallowm, MD
07:00 AM - 05:00 PM EDT Abstract 080 - Cure for the Uncommon CSF Leak: Surgical Outcomes of CSF-Venous Fistula Repair
Monique Maria Montenegro, MD
07:00 AM - 05:00 PM EDT Abstract 081 - Carotid Cavernous Fistula Mimicking Hemicrania Continua
Kendra K. Davis
07:00 AM - 05:00 PM EDT Abstract 082 - Thunderclap Headache as Presentation of Autonomic Dysreflexia in a Woman With Neuromyelitis Optica. Case Report and Literature Review.
Veronica Astrid Moreno Gomez, MD
07:00 AM - 05:00 PM EDT Abstract 083 - Stroke-like Migraine Attacks after Radiation Therapy (SMART) Syndrome: “Stroke-Like Migraine or Migrainous Stroke?”
Ahmed Abbas, MD
07:00 AM - 05:00 PM EDT Abstract 084 - Headache as the Presenting Symptom of COVID-19 in Two Patients with a History of Migraine
Jyotika Singh
07:00 AM - 05:00 PM EDT Abstract 085 - Spontaneous Intracranial Hypotension Presenting as Postural Headache and Cranial VI Palsy: A Case Report
Leonard Shou, DO
07:00 AM - 05:00 PM EDT Abstract 086 - Acute migraine anesthetic nasal spray treatment during the COVID-19 pandemic
Sarah Molly Bobker, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Decreasing Burden of Chronic Migraine in Pregnancy by Addressing Medication Overuse Headache
Ami Zarrillo Cuneo, MD
07:00 AM - 05:00 PM EDT Abstract 088 - US Real-world Patient Characteristics, Acute Medication Use, and Treatment Patterns for Patients Initiating Fremanezumab
Michael Seminerio
07:00 AM - 05:00 PM EDT Abstract 089 - Migraine Patients Exhibit Increased Risk Of Opioid Dependence With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis
Diego Fernandez-Vial
07:00 AM - 05:00 PM EDT Abstract 090 - Acute Migraine Medication and Medication Overuse Headache: A Systematic Literature Review
Alison Deighton
07:00 AM - 05:00 PM EDT Abstract 091 - Migraine Patients Exhibit Risk Of Medication Overuse Headache With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis
Ali Mohajer, PhD
07:00 AM - 05:00 PM EDT Abstract 092 - Developing an Outpatient Infusion Center for Treatment of Pediatric Headache Disorders Redirects Point of Care and Decreases Heath Care Costs
Hannah Shapiro, MD
07:00 AM - 05:00 PM EDT Abstract 093 - Early Utilization of SPG Block for the Treatment of Acute Migraine Headache in the Pediatric Emergency Department
Mary Haywood
07:00 AM - 05:00 PM EDT Abstract 094 - Safety and Efficacy of Repetitive Dihydroergotamine Infusion for the Acute Treatment of Refractory Chronic Migraine in Hospitalized Patients with Vascular Risk Factors
Clinton G. Lauritsen, MD
07:00 AM - 05:00 PM EDT Abstract 095 - Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis
Katherine Sommer
07:00 AM - 05:00 PM EDT Abstract 096 - What Role do Urgent Care Centers Play in Headache Management? A Quality Improvement Study of Select Urgent Care Facilities
Annika Ehrlich, NP
07:00 AM - 05:00 PM EDT Abstract 097 - Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody for the Preventive Treatment of Migraine
Susan M. Pederson
07:00 AM - 05:00 PM EDT Abstract 098 - Single Therapeutic Doses of Atogepant Are Not Associated With a Clinically Relevant Drug-Drug Interaction When Coadministered With Acetaminophen or Naproxen
Ramesh *use 388303 Boinpally
07:00 AM - 05:00 PM EDT Abstract 099 - Development of a Novel, Clinical-stage Drug for the Prevention of Migraine Based on Receptor Activity Mapping and Achievement of a Target Receptor Profile
Miguel Guzman
07:00 AM - 05:00 PM EDT Abstract 100 - An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of Migraine With or Without Aura in Pediatric Participants
Jennifer W. McVige, MD
07:00 AM - 05:00 PM EDT Abstract 101 - Coadministration of Single Therapeutic Oral Doses of Atogepant and Sumatriptan Produces No Clinically Relevant Drug-Drug Interactions
Matthew Butler
07:00 AM - 05:00 PM EDT Abstract 102 - Evaluation of Pharmacokinetic Interactions and Safety of Atogepant Coadministered With Quinidine Gluconate
Ramesh *use 388303 Boinpally
07:00 AM - 05:00 PM EDT Abstract 103 - Role of Circadian Rhythm on the Effectiveness of Onabotulinum Toxin A (BTA) Injections as Preventive Therapy for Chronic Migraines (CM)
Andres Augustus Arciniegas, MD, MSHA, MSHI
07:00 AM - 05:00 PM EDT Abstract 104 - Changes in the Muscles of Mastication in patients with Trigeminal Neuralgia: Lessons from the radiosurgical cohort.
Nasser Mohammed, MBBS
07:00 AM - 05:00 PM EDT Abstract 105 - Case Of Percutaneous Trigeminal Ganglion Block With Intraoperative Monitoring Of Blink Reflex For Refractory Trigeminal Neuralgia.
Sachin M. Bhagavan, MD
07:00 AM - 05:00 PM EDT Abstract 106 - The Application of Ultrasound in Diagnosis and Surveillance of Chronic Occipital Neuralgia
Elham Azizi, MD
07:00 AM - 05:00 PM EDT Abstract 107 - Preference for Rimegepant and Improved Clinical Global Impression of Change Among Adults With a History of Triptan Treatment Failure: Results from a Long-Term Open-Label Safety Study
Ira M. Turner, MD
07:00 AM - 05:00 PM EDT Abstract 108 - Low Rates of Rescue Medication Usage in Subjects Treated with a Single Dose of Rimegepant 75 mg for the Acute Treatment of Migraine: Results from 3 Phase 3 Clinical Trials
Timothy *USE ID 123628 Smith
07:00 AM - 05:00 PM EDT Abstract 109 - Acute Treatment of Migraine with Rimegepant Improves Health Related Quality of Life in Adults With a History of Triptan Treatment Failure: Results from a Long-Term, Open-Label Safety Study
Ira M. Turner, MD
07:00 AM - 05:00 PM EDT Abstract 110 - Improved Functionality, Satisfaction, and Global Impression of Change With Ubrogepant for the Acute Treatment of Migraine in Triptan Insufficient Responders
Jordan Lateiner, MS, MBA
07:00 AM - 05:00 PM EDT Abstract 111 - A Novel Approach to Defining Success in the Acute Treatment of Migraine: Pooled Results From the ACHIEVE I and ACHIEVE II Trials
Richard B. Lipton, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 112 - Lasmiditan Efficacy in Mild Versus Moderate or Severe Migraine Headaches
Maurice Borges Vincent, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 113 - Onset of Action of a Zolmitriptan Microneedle System (M207, Qtrypta™) for Migraine: Comparison with Recent Early Time to Onset Recommendations, Pain Relief Results and Placebo Response
Deborah I. Friedman, MD, MPH, FAAN
07:00 AM - 05:00 PM EDT Abstract 114 - MSQ Utility Mapping of Rimegepant by Change in Monthly Migraine Days
Karissa Johnston
07:00 AM - 05:00 PM EDT Abstract 115 - Patient acceptability of INP104 aligns with the unmet needs identified in I-BEAM survey.
Stephen Bevan Shrewsbury, MD
07:00 AM - 05:00 PM EDT Abstract 116 - Discrete Choice Experiment to Understand Patient Preferences for Self-Injectable Preventive Treatments for Migraine – A quantitative pilot
Jaein Seo
07:00 AM - 05:00 PM EDT Abstract 117 - Evaluation of Cardiovascular Risks in Patients Treated With Longer-term Exposure to Galcanezumab
Richard Kovacs
07:00 AM - 05:00 PM EDT Abstract 118 - Number Needed to Treat/Harm for Fremanezumab in Patients Who Had Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes
Messoud Ashina, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 119 - Real-world Adherence, Persistence, Switching, and Reinitiation in Patients Prescribed AJOVY in US Physician Practices
Krishna Tangirala
07:00 AM - 05:00 PM EDT Abstract 120 - Real-world Reductions in Migraine and Headache Days for Patients With Chronic and Episodic Migraine Initiating Fremanezumab in the US
Joshua M. Cohen, MD
07:00 AM - 05:00 PM EDT Abstract 121 - Improvements in Patient-reported Migraine Pain Intensity and Composite Migraine Symptoms With Fremanezumab in the Real World
Alexander Mauskop, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 122 - Baseline Comorbidities and Changes in Acute Medication Use by Quarterly and Monthly Dosing Regimen in Patients Prescribed AJOVY in US Physician Practices
Lynda Krasenbaum
07:00 AM - 05:00 PM EDT Abstract 123 - Real-World Adherence, Persistence, Switching, and Reinitiation by Quarterly and Monthly Dosing Regimen in Patients Prescribed AJOVY in US Physician Practices
Krishna Tangirala
07:00 AM - 05:00 PM EDT Abstract 124 - Safety and Tolerability of Eptinezumab in Patients With Migraine: A Pooled Analysis of 5 Clinical Trials
Timothy *USE ID 123628 Smith
07:00 AM - 05:00 PM EDT Abstract 125 - Effect of Fremanezumab on the Total Burden of Migraine in Patients with Episodic or Chronic Migraine: Findings from 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
Christina Sun-Edelstein, MD
07:00 AM - 05:00 PM EDT Abstract 126 - Single Center Experience of mAbs-CGRP Use for Migraine Prevention
Christopher Joseph Bondoc, MD
07:00 AM - 05:00 PM EDT Abstract 127 - Patient Preference for Early Onset of Efficacy in Migraine Prevention
Paul Winner, DO, FAAN
07:00 AM - 05:00 PM EDT Abstract 128 - Adherence to Guidelines and Outcomes Among People with Migraine Receiving Preventive Medication
Richard B. Lipton, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 129 - Estimated migraine acute-therapy savings, from MMD reduction achieved with preventive treatment
Thomas O'Connell
07:00 AM - 05:00 PM EDT Abstract 130 - Headache diagnosis and treatment: A knowledge and needs assessment among pain medicine specialists
Jackie Yang
07:00 AM - 05:00 PM EDT Abstract 132 - Effectiveness Of Nonpharmacologic Therapy In Migraine Prophylaxis
Anusha Badveli, DM
07:00 AM - 05:00 PM EDT Abstract 133 - Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention treatment of migraine, Kuwait experience.
Hasan Ashkanani
07:00 AM - 05:00 PM EDT Abstract 134 - Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Treatment of Patients with Concussion
Megan Rooney
07:00 AM - 05:00 PM EDT Abstract 135 - Acute Onset of Thrombotic Thrombocytopenic Purpura after Erenumab Treatment: A Case Report
Jaspreet Johal, MD
07:00 AM - 05:00 PM EDT Abstract 136 - Episodic and Chronic Cluster Headache: Evaluation of Health-Related Quality of Life Impact and Estimation of Health-state Utilities
Antje Tockhorn-Heidenreich
07:00 AM - 05:00 PM EDT Abstract 137 - MIDAS Disability Grades are Associated with Total Health Care and Pharmaceutical Costs – A US-Based Real World Longitudinal Analysis
Diego Fernandez-Vial
07:00 AM - 05:00 PM EDT Abstract 138 - Use of Medical Education Program to Identify Practice Gaps Among Neurologists in the Use of Preventive Therapies for the Management of Migraine
John Maeglin
07:00 AM - 05:00 PM EDT Abstract 139 - Migraine Science Collaborative: A Novel Innovative Web-based Networking and Communication Platform To Enhance And Advance Migraine Research
Monica Prasad Mallampalli, PhD
07:00 AM - 05:00 PM EDT Abstract 140 - Tracking the Evolution of Non-Headache Symptoms Through the Migraine Attack
Roberta Messina, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 141 - Acute Quadriplegic Migraine Presenting As Spinal Cord Infarction.
Hashaam Arshad, MD, MBBS
07:00 AM - 05:00 PM EDT Abstract 142 - Vegetables and Fruits Intake and Brain in Pain Quantification of Vegetables and Fruits Servings in Migraine Patients at Large Tertiary Headache Center
Arnav Narula
07:00 AM - 05:00 PM EDT Abstract 143 - Impact of the Vega Healthcare Provider Report on Provider Satisfaction and Decision-Making Confidence in Simulated Patient Portal Visits for Migraine
Paul B. Rizzoli, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 144 - Cranial Autonomic Symptoms in Migraine
Nazia Karsan, PhD, MBBS
07:00 AM - 05:00 PM EDT Abstract 145 - Polysomnography and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients with Transformed Migraine
Mohammed A. ElSherif, MD, PhD, FAAN
07:00 AM - 05:00 PM EDT Abstract 146 - A New Vision in Headache Medicine: A Survey of Headache Specialists' Utilization of Telehealth in Their Practice
Mia T. Minen, MD, FAAN
Faculty Disclosures
Timothy R. Smith, MD The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
David B. Kudrow, MD Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Jiang Li Jiang Li has received personal compensation for serving as an employee of teva.
Hamsa Sahib Hamsa Sahib has nothing to disclose.
Maria T. Goicochea No disclosure on file
Paolo Misci Paolo Misci has nothing to disclose.
Lisa Kerr Lisa Kerr has received personal compensation for serving as an employee of Eli Lilly and Company.
Danielle McGeeney Danielle McGeeney has received personal compensation for serving as an employee of AbbVie. Danielle McGeeney has received stock or an ownership interest from AbbVie.
Lakshminarasimhaiah Krishnamurthy, MD Dr. Krishnamurthy has nothing to disclose.
Nahum Nesher Steve Barash has received personal compensation for serving as an employee of Teva. Steve Barash has received stock or an ownership interest from Teva.
Maya Vizel Maya Vizel has received personal compensation for serving as an employee of Theranica Bio-Electronics.
Sharon Kautz Sharon Kautz has nothing to disclose.
Janette Contreras-De Lama Janette Contreras-De Lama has received personal compensation for serving as an employee of AbbVie. Janette Contreras-De Lama has stock in AbbVie.
Sally Haskell No disclosure on file
Anthony J Zagar Anthony J Zagar has received personal compensation for serving as an employee of Eli Lilly.
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Silberstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alergan. Dr. Silberstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Silberstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Silberstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Davies McFarland & Carroll, LLC. Dr. Silberstein has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for SHEEHEY FURLONG & BEHM P.C.. The institution of Dr. Silberstein has received research support from Lundbeck. The institution of Dr. Silberstein has received research support from abbvie. The institution of Dr. Silberstein has received research support from lundbeck. Dr. Silberstein has received publishing royalties from a publication relating to health care.
Marianthi-Anna Kioumourtzoglou, 7882 Marianthi-Anna Kioumourtzoglou, 7882 has nothing to disclose.
Lawrence *use 118531 Severt No disclosure on file
Yaron Gruper Yaron Gruper has nothing to disclose.
Jaspreet Johal, MD Dr. Johal has nothing to disclose.
Suzanne Klise Suzanne Klise has received personal compensation for serving as an employee of Eli Lilly and Company. Suzanne Klise has received stock or an ownership interest from Eli Lilly and Company.
Brent Allan No disclosure on file
Shivani Pandya Shivani Pandya has received personal compensation for serving as an employee of StatInMed.
Mette Josiassen Mette Josiassen has received personal compensation for serving as an employee of Lundbeck. Mette Josiassen has received personal compensation in the range of $0-$499 for serving as a Lecturer with University of Copenhagen.
Barbara Schaeffler No disclosure on file
Jasem Yousef Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Henna Sawhney, MBBS Dr. Sawhney has nothing to disclose.
Hartmut Gobel Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Elli Lilly. Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elli Lilly. Hartmut Gobel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Hartmut Gobel has received publishing royalties from a publication relating to health care. Hartmut Gobel has received personal compensation in the range of $10,000-$49,999 for serving as a Innovator with Ministry of Health.
Karthik Nagaraj Dr. Nagaraj has nothing to disclose.
Manali Phadke Manali Phadke has nothing to disclose.
David M. Biondi, DO, FAAN Dr. Biondi has received personal compensation for serving as an employee of Cohen Veterans Bioscience, Inc. Dr. Biondi has received personal compensation for serving as an employee of Alder Biopharmaceuticals, Inc. Dr. Biondi has received stock or an ownership interest from Johnson & Johnson . The institution of Dr. Biondi has received research support from US Department of Defense .
Juline Bryson, MD Dr. Bryson has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Bryson has received stock or an ownership interest from Teva .
Ann Hartry Ann Hartry has received personal compensation for serving as an employee of Lundbeck, LLC.
Jaein Seo Jaein Seo has received personal compensation for serving as an employee of Evidera.
Brian Maxwell Plato, DO Dr. Plato has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Plato has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Plato has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Plato has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Plato has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Plato has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven.
Jose A. Vivancos Mora No disclosure on file
Jakub Jedynak Jakub Jedynak has received personal compensation for serving as an employee of Lilly. Jakub Jedynak has received stock or an ownership interest from Lilly.
Alicia Gonzalez-Martinez, MD Dr. Gonzalez-Martinez has nothing to disclose.
Theodora Andriotis, DO Dr. Andriotis has nothing to disclose.
Aye French No disclosure on file
Nathan L. Bennett, MD Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan / AbbVie. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan / Abbvie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Muhammad Fawad Ishfaq, MD Dr. Ishfaq has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Daniel Mandel, MD Dr. Mandel has nothing to disclose.
Rocio Lopez Rocio Lopez has nothing to disclose.
Addie M. Peretz, MD Dr. Peretz has nothing to disclose.
Angela Jeanette Argyropoulos, MD Dr. Argyropoulos has nothing to disclose.
Corey Goldsmith, MD, FAAN Dr. Goldsmith has received publishing royalties from a publication relating to health care.
Jonathan P. Gladstone, MD Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lily. Dr. Gladstone has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aralez. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Gladstone has received publishing royalties from a publication relating to health care.
Shannon White Shannon White has nothing to disclose.
Gabriel Paiva da Silva Lima Gabriel Paiva da Silva Lima has received personal compensation for serving as an employee of Amgen Inc. Gabriel Paiva da Silva Lima has received stock or an ownership interest from Amgen Inc.
Ellen Dennehy Ellen Dennehy has received personal compensation for serving as an employee of Eli Lilly. Ellen Dennehy has stock in Eli Lilly.
Sigrid Crawford Sigrid Crawford has received personal compensation for serving as an employee of RTI Health Solutions.
Virginia L. Stauffer Virginia L. Stauffer has received personal compensation for serving as an employee of Eli Lilly and Company. Virginia L. Stauffer has received stock or an ownership interest from Eli Lilly and company.
Anand R. Shewale Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
George Chakhava, MD, PhD Prof. Chakhava has nothing to disclose.
Yaiza Garcia Del Alamo Yaiza García Del Álamo has nothing to disclose.
Sonja Ortler, MD Dr. Ortler has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Holland Detke Holland Detke has received personal compensation for serving as an employee of Eli Lilly and Company. Holland Detke has received stock or an ownership interest from Eli Lilly and Company.
Belinda Udeh The institution of Belinda Udeh has received research support from Teva Pharmceuticals. Belinda Udeh has received publishing royalties from a publication relating to health care.
Dylan Lis Mr. Lis has nothing to disclose.
M Tsai M Tsai has received personal compensation for serving as an employee of Eli Lilly and Company. M Tsai has received stock or an ownership interest from Eli Lilly and Company.
Kaicheng Wang Kaicheng Wang has nothing to disclose.
Stephanie J. Nahas, MD, FAAN Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert/talent for CME event with Medscape/WebMD.
Laura *use 387110 Yunes-Medina Laura Yunes-Medina has received personal compensation for serving as an employee of Eli Lilly and Company.
Caroline Burk Caroline Burk has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan, Inc.
Thomas O'Connell The institution of Thomas O'Connell has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharmaceuticals. Thomas O'Connell has received stock or an ownership interest from Medicus Economics.
Alexander Mauskop, MD, FAAN Dr. Mauskop has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lily. Dr. Mauskop has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mauskop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Claire Haist Sandoe, MD Dr. Sandoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aralez. Dr. Sandoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Sandoe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Sandoe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Sihui Zhao Sihui Zhao has received personal compensation for serving as an employee of AbbVie. Sihui Zhao has received stock or an ownership interest from AbbVie.
Nicole Kowalczyk Nicole Kowalczyk has nothing to disclose.
Lisa McConnachie Lisa McConnachie has received personal compensation for serving as an employee of Impel Neuropharma.
Hon Chan Hon Chan has received personal compensation for serving as an employee of Allergan / AbbVie. Hon Chan has received stock or an ownership interest from Allergan\AbbVie.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Mrudula Glassberg Mrudula Glassberg has received personal compensation for serving as an employee of Novartis Pharmaceutical Corporation. Mrudula Glassberg has received personal compensation for serving as an employee of Johnson & Johnson.
Susan M. Pederson Susan M. Pederson has nothing to disclose.
Ju Ji Ju Ji has nothing to disclose.
Aniket Natekar Mr. Natekar has nothing to disclose.
Clinton G. Lauritsen, MD Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
Silvie Belaskova Silvie Belaskova has nothing to disclose.
Sung Y. Yu Sung Y. Yu has received personal compensation for serving as an employee of Abbvie. Sung Y. Yu has received stock or an ownership interest from Abbvie.
Abhijeet Jakate, PhD No disclosure on file
Kamen Kamenov No disclosure on file
Phebe Kemmer, PhD Dr. Kemmer has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Kemmer has received stock or an ownership interest from Eli Lilly and Company.
Shawn Elms Shawn Elms has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Elizabeth Brunner Elizabeth Brunner has received personal compensation for serving as an employee of Lundbeck. Elizabeth Brunner has received stock or an ownership interest from Lundbeck.
Jin Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Elham Azizi, MD Dr. Azizi has nothing to disclose.
John Latham No disclosure on file
Natalia Murinova, MD, FAAN Dr. Murinova has nothing to disclose.
Laurent David Laurent David has nothing to disclose.
Robert E. Shapiro, MD, PhD, FAAN Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Shapiro has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Shapiro has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for EEOC.
J Scott Andrews J Scott Andrews has received personal compensation for serving as an employee of Eli Lilly & Company. J Scott Andrews has received stock or an ownership interest from Eli Lilly & Company.
Larry Charleston, IV, MD, MSc, FAHS Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Maurice Borges Vincent, MD, PhD Prof. Vincent has received personal compensation for serving as an employee of Eli Lilly and Company. Prof. Vincent has stock in Eli Lilly and Company.
Matias Ferraris Matias Ferraris has received personal compensation for serving as an employee of Novartis Pharma AG. An immediate family member of Matias Ferraris has received stock or an ownership interest from Novartis Pharma AG.
Ashley Iannone Ashley Iannone has nothing to disclose.
Ali Mohajer, PhD Dr. Mohajer has received personal compensation for serving as an employee of Qral Group, LLC.
Hashaam Arshad, MD, MBBS No disclosure on file
Mohammed A. ElSherif, MD, PhD, FAAN Dr. ElSherif has nothing to disclose.
William B. Young, MD, FAAN Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Timothy *USE ID 123628 Smith The institution of Timothy R. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso. The institution of Timothy R. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. The institution of Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Timothy R. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Timothy R. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Neuropharma. The institution of Timothy R. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. The institution of Timothy R. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan (Abbvie). Timothy R. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Timothy R. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. The institution of Timothy R. Smith has received research support from Allergan. The institution of Timothy R. Smith has received research support from Amgen. The institution of Timothy R. Smith has received research support from Biohaven. The institution of Timothy R. Smith has received research support from Charleston Laboratories. The institution of Timothy R. Smith has received research support from Electrocore. The institution of Timothy R. Smith has received research support from Impel Neuropharma. The institution of Timothy R. Smith has received research support from Lilly. The institution of Timothy R. Smith has received research support from Lundbeck (Alder). The institution of Timothy R. Smith has received research support from Satsuma. The institution of Timothy R. Smith has received research support from Theranica. The institution of Timothy R. Smith has received research support from Vorso. The institution of Timothy R. Smith has received research support from Boehringer Ingelheim. The institution of Timothy R. Smith has received research support from Novartis. The institution of Timothy R. Smith has received research support from Novo Nordisk. The institution of Timothy R. Smith has received research support from Teva. The institution of Timothy R. Smith has received research support from Nocira. The institution of Timothy R. Smith has received research support from Aeon Pharmaceuticals. The institution of Timothy R. Smith has received research support from Eliem Pharmaceuticals. Timothy R. Smith has a non-compensated relationship as a Member, Board of Directors with National Headache Foundation that is relevant to AAN interests or activities.
Zubair Ahmed, MD Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Jyotika Singh Ms. Singh has nothing to disclose.
David Seminowicz The institution of David Seminowicz has received research support from NIH.
Ilaria Cetta, MD Dr. Cetta has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Ira M. Turner, MD Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan, Amgen, Novartis, Teva, Lilly, Lundbeck, Biohaven,Impel. Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Teva, Allergan, Biohaven, Lilly, Lundbeck, Theranica, Revance. Dr. Turner has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, Teva, Novartis, Lundbeck, Lilly. The institution of Dr. Turner has received research support from Allergan, Amgen, Biohaven, Lilly, Lundbeck, Theranica.
Ramesh *use 388303 Boinpally Ramesh Boinpally has received personal compensation for serving as an employee of Allergan/Abbvie. Ramesh Boinpally has stock in Abbvie. Ramesh Boinpally has stock in Allergan. Ramesh Boinpally has received intellectual property interests from a discovery or technology relating to health care.
Walter Stewart Walter Stewart has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for amgen. Walter Stewart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for grifols.
Messoud Ashina, MD, PhD Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Benjamin Friedman Benjamin Friedman has nothing to disclose.
Sau Mui Chan-Goh Sau Mui Chan-Goh has nothing to disclose.
Krista Schroeder Krista Schroeder has received personal compensation for serving as an employee of Eli Lilly and Company.
John Ney, MD, MPH, FAAN Dr. Ney has received personal compensation for serving as an employee of Surgican Neuromonitoring Associates, PLLC. Dr. Ney has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medincell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Ney has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society for Neuromonitoring.
Marcel Budica Marcel Budica has nothing to disclose.
Mario Ortega No disclosure on file
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Caitlin Thomas Caitlin Thomas has received personal compensation for serving as an employee of Evidera.
Antje Tockhorn-Heidenreich Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Eli Lilly and Company. An immediate family member of Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Evidera. Antje Tockhorn-Heidenreich has received stock or an ownership interest from Eli Lilly and Company . An immediate family member of Antje Tockhorn-Heidenreich has received stock or an ownership interest from PPD.
Helen C. Haley Miss Haley has nothing to disclose.
Vi Le Vi Le has nothing to disclose.
John Maeglin Mr. Maeglin has nothing to disclose.
Sarah Ann Mangold, DO Ms. Mangold has nothing to disclose.
Blake Bulloch Blake Bulloch has nothing to disclose.
Brett Dabruzzo, PharmD Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Clayton Shanahan Mr. Shanahan has nothing to disclose.
Alison Deighton Alison Deighton has nothing to disclose.
Laszlo Mechtler, MD, FAAN, FASN Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Thomas Armer Thomas Armer has received personal compensation for serving as an employee of Xoc Pharmaceuticals. Thomas Armer has received stock or an ownership interest from Xoc Pharmaceuticals.
Joshua M. Cohen, MD No disclosure on file
Jason Hinzman Jason Hinzman has received personal compensation for serving as an employee of Eli Lilly. Jason Hinzman has received stock or an ownership interest from Eli Lilly.
Oscar Patterson-Lomba Oscar Patterson-Lomba has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Emel Serap Nery Emel Serap Nery has received personal compensation for serving as an employee of Eli Lilly and Company.
Kristina M Fanning, PhD The institution of Kristina Fanning has received research support from Abbvie. The institution of Kristina Fanning has received research support from NYC Langone Health . The institution of Kristina Fanning has received research support from Allay Lamp. The institution of Kristina Fanning has received research support from Juva Health.
Julian Casciano Julian Casciano has nothing to disclose.
Nina Yakovlevna Riggins, MD, FAAN Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Arnav Narula An immediate family member of Arnav Narula has received personal compensation for serving as an employee of MAQ Software.
Lynda Krasenbaum Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Jade Suehyun Park, MD Ms. Park has nothing to disclose.
Yamin Sallowm, MD Dr. Sallowm has nothing to disclose.
Kayla Kaplan Kayla Kaplan has nothing to disclose.
Matthew Butler Matthew Butler has received personal compensation for serving as an employee of Allergan / Abbvie. Matthew Butler has received stock or an ownership interest from Allergan/Abbvie.
Eric M. Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Alexander Knudson Alexander Knudson has nothing to disclose.
Umer Najib, MD, FAAN Dr. Najib has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan . The institution of Dr. Najib has received research support from Teva. The institution of Dr. Najib has received research support from Electrocore. The institution of Dr. Najib has received research support from Theranica . The institution of Dr. Najib has received research support from Eli Lilly.
Samuel Krimmel Samuel Krimmel has nothing to disclose.
Adnan I. Qureshi, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Kevin Marsh Kevin Marsh has received personal compensation for serving as an employee of Evidera. The institution of Kevin Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Kevin Marsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CEPI. Kevin Marsh has received stock or an ownership interest from PPD.
Abhishek Kengen, MD Dr. Kengen has nothing to disclose.
Tally Largent-Milnes Tally Largent-Milnes has received personal compensation for serving as an employee of Expesicor. Tally Largent-Milnes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expesicor. Tally Largent-Milnes has received intellectual property interests from a discovery or technology relating to health care.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Elyse Stock Elyse Stock has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Flagship Pioneering Management. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol-Myers Squibb. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Optinose. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abpro. An immediate family member of Elyse Stock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adagio. Elyse Stock has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Biohaven Pharmaceuticals. Elyse Stock has received stock or an ownership interest from Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received stock or an ownership interest from BIohaven Pharmaceuticals.
DENNIS REVICKI DENNIS REVICKI has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. DENNIS REVICKI has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. DENNIS REVICKI has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Patient Reported Outcomes. The institution of DENNIS REVICKI has received research support from Amgen. The institution of DENNIS REVICKI has received research support from Allergan.
Naomi Sacks Naomi Sacks has nothing to disclose.
Mohamed Abdelsalam Mohamed ABDELSALAM has nothing to disclose.
Darren Wilbraham Darren Wilbraham has received personal compensation for serving as an employee of Eli Lilly and Company.
Kathleen B. Mullin, MD Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Reena Rastogi No disclosure on file
Sait Ashina, MD Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ashina has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Ryuhei Kono No disclosure on file
Jenny Guiracocha Jenny Guiracocha has nothing to disclose.
Jasna Hocevar-Trnka Jasna Hocevar-Trnka has received personal compensation for serving as an employee of Impel NeuroPharma.
Bjoern Sperling Bjoern Sperling has received personal compensation for serving as an employee of Lundbeck . Bjoern Sperling has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rehaler . Bjoern Sperling has stock in Lundbeck .
Rajeev Ayyagari, PhD Rajeev Ayyagari, PhD has received personal compensation for serving as an employee of Analysis Group, Inc. .
Stefan Wilhelm Stefan Wilhelm has received personal compensation for serving as an employee of Eli Lilly. Stefan Wilhelm has received stock or an ownership interest from Eli Lilly.
Agathe Le Lay Agathe Le Lay has received personal compensation for serving as an employee of Lundbeck.
Annika Lindsten Annika Lindsten has received personal compensation for serving as an employee of H Lundbeck A/S.
Mat D. Davis Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
Mark Bangs Mark Bangs has received personal compensation for serving as an employee of Eli Lilly. Mark Bangs has received stock or an ownership interest from Eli Lilly.
Rachel Morello-Frosch The institution of Rachel Morello-Frosch has received research support from NIH. The institution of Rachel Morello-Frosch has received research support from Cal-EPA. The institution of Rachel Morello-Frosch has received research support from US-EPA.
Hend Abulsayen, MD Dr. Abulsayen has nothing to disclose.
Lois Lamerato The institution of Lois Lamerato has received research support from Centers for Disease Control. The institution of Lois Lamerato has received research support from National Institutes of Health. The institution of Lois Lamerato has received research support from eMaxHealth. The institution of Lois Lamerato has received research support from Evidera. The institution of Lois Lamerato has received research support from AstraZeneca. The institution of Lois Lamerato has received research support from Policy Analysis, Inc. The institution of Lois Lamerato has received research support from Xcenda. The institution of Lois Lamerato has received research support from Pfizer.
Karen Samaan Karen Samaan has received personal compensation for serving as an employee of Eli LIlly.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Hsinlin T. Cheng, MD Dr. Cheng has nothing to disclose.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
Josh Rowe Josh Rowe has received personal compensation for serving as an employee of Abbvie. Josh Rowe has received stock or an ownership interest from Abbvie.
Melissa Darsey, PA Melissa Darsey has a non-compensated relationship as a Clinical Research Assistant with Allergan that is relevant to AAN interests or activities.
Todd J. Schwedt, MD, FAAN Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Evelyn Du Evelyn Du has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Simin Baygani Simin Baygani has received personal compensation for serving as an employee of Eil Lilly & Company. Simin Baygani has received stock or an ownership interest from Eli Lilly & Company.
Chelsea Leroue Chelsea Leroue has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tremeau. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddys. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from Celgene. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Director with American Migraine Foundation that is relevant to AAN interests or activities.
Evan Popoff Evan Popoff has nothing to disclose.
Yoel Kessler Yoel Kessler has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Swathi Beladakere Ramaswamy, MD Dr. Beladakere Ramaswamy has nothing to disclose.
Mia T. Minen, MD, FAAN Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Katherine Selzler Katherine Selzler has received personal compensation for serving as an employee of Eli Lilly and Company. Katherine Selzler has received stock or an ownership interest from Eli Lilly and Company.
Maria Soledad Rodriguez Perez Mrs. Rodriguez Perez has nothing to disclose.
Todd Vanderah Todd Vanderah has nothing to disclose.
Michelle Scalley-Kim Michelle Scalley-Kim has received personal compensation for serving as an employee of Alder Biopharmaceuticals. Michelle Scalley-Kim has received personal compensation for serving as an employee of Lundbeck . Michelle Scalley-Kim has received personal compensation for serving as an employee of Seattle Genetics. Michelle Scalley-Kim has received stock or an ownership interest from Seattle Genetics. Michelle Scalley-Kim has received stock or an ownership interest from Alder Biopharmaceuticals.
Jonathan Cheponis, MD Dr. Cheponis has nothing to disclose.
Katelyn Cutts Katelyn Cutts has nothing to disclose.
Diane L. Amend, PhD No disclosure on file
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Vincent Martin No disclosure on file
Judith Krikke Judith Krikke has received personal compensation for serving as an employee of Eli Lilly and Company.
Camilo Ramiro Gomez, MD, FAAN Dr. Gomez has nothing to disclose.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Janet Ford Janet Ford has received personal compensation for serving as an employee of Eli Lilly and Company . Janet Ford has received stock or an ownership interest from Eli Lilly and Company .
Emmanuelle Schindler, MD, PhD The institution of Dr. Schindler has received research support from CH-TAC, LLC. The institution of Dr. Schindler has received research support from Wallace Research Foundation.
Marco Navetta Marco Navetta has received personal compensation for serving as an employee of Amgen.
H. Christoph Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Jason P Sheehan, 2558 Jason P Sheehan, 2558 has nothing to disclose.
Michael Phelan Michael Phelan has nothing to disclose.
Benjamin M. Frishberg, MD, FAAN Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Frishberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Frishberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Frishberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Frishberg has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Frishberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Frishberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela-Bio. Dr. Frishberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Frishberg has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Frishberg has a non-compensated relationship as a Delegate with AMA that is relevant to AAN interests or activities.
Meghan Lovegren Meghan Lovegren has received personal compensation for serving as an employee of Biohaven Pharmaceutials, Inc.. Meghan Lovegren has stock in Biohaven Pharmaceuticals, Inc..
Frederick Godley Frederick Godley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Frederick Godley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals.
Kevin Duffy Kevin Duffy has received personal compensation for serving as an employee of Eli Lilly.
Ali Ezzati, MD Dr. Ezzati has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mist Research. Dr. Ezzati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioDelivery Sciences International (BDSI) . The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Philip Wang Mr. Wang has nothing to disclose.
Richard Wenzel Richard Wenzel has received personal compensation for serving as an employee of Eli Lilly. Richard Wenzel has received stock or an ownership interest from Eli Lilly.
Kiana Moussavi, MD Ms. Moussavi has nothing to disclose.
Amy J Kovacik Amy J Kovacik has nothing to disclose.
Martha Port Martha Port has received personal compensation for serving as an employee of Eli Lilly and Company. Martha Port has received stock or an ownership interest from Eli Lilly and Company.
Bharati Sanjanwala Bharati Sanjanwala has nothing to disclose.
Gina Dumkrieger, PhD Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Hannah Shapiro, MD Dr. Shapiro has nothing to disclose.
Bradley J. Katz, MD, PhD Bradley J. Katz, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for axon optics, LLC. Bradley J. Katz, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for self employed. Bradley J. Katz, MD, PhD has received stock or an ownership interest from Pfizer. Bradley J. Katz, MD, PhD has received intellectual property interests from a discovery or technology relating to health care.
Laur Marius Birlea, MD Dr. Birlea has nothing to disclose.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Angelo Camporeale Angelo Camporeale has received personal compensation for serving as an employee of Eli Lilly Italy. Angelo Camporeale has received stock or an ownership interest from Eli Lilly & Co.
Denise Chou Denise Chou has received personal compensation for serving as an employee of Amgen. Denise Chou has received stock or an ownership interest from Amgen.
Marta Bustamante Marta Bustamante has nothing to disclose.
Veeranna Mohan Gadad, MBBS Dr. Gadad has nothing to disclose.
Negar Moheb, MD Dr. Moheb has nothing to disclose.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ElevateMed. Dr. Vargas has stock in Eli Lilly. An immediate family member of Dr. Vargas has stock in Pfizer. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Lynn Do, PharmD Dr. Do has received personal compensation for serving as an employee of Eli Lilly.
Fei Xue Fei Xue has received personal compensation for serving as an employee of Amgen Inc.
Jean Engels Jean Engels has received personal compensation for serving as an employee of Zosano Pharma. Jean Engels has received stock or an ownership interest from Zosano Pharma.
Karen Carr Karen Carr has received stock or an ownership interest from Teva Pharmaceuticals. An immediate family member of Karen Carr has received stock or an ownership interest from Genentech.
Andres Augustus Arciniegas, MD, MSHA, MSHI Dr. Arciniegas has nothing to disclose.
Katherine Ross Katherine Ross has nothing to disclose.
Alexander Rubin Alexander Rubin has nothing to disclose.
Danielle D. DeSouza, PhD Dr. DeSouza has nothing to disclose.
Cherisse Mecham Ms. Mecham has nothing to disclose.
Tommi Tervonen Tommi Tervonen has received personal compensation for serving as an employee of Evidera.
Nazia Karsan, PhD, MBBS Dr. Karsan has nothing to disclose.
Rinat Ariely Rinat Ariely has received personal compensation for serving as an employee of Teva Pharmaceuticals. Rinat Ariely has received stock or an ownership interest from Teva Pharmaceuticals.
Erica Yim Erica Yim has nothing to disclose.
Lauren Doyle Strauss, DO Dr. Strauss has a non-compensated relationship as a Secretary with Southern Headache Society that is relevant to AAN interests or activities.
Dennique Khanns Dennique Khanns has nothing to disclose.
Lynda Doward LYNDA DOWARD has received personal compensation for serving as an employee of RTI Health Solutions.
Clint Forsythe Clint Forsythe has received personal compensation for serving as an employee of Allergan. Clint Forsythe has received personal compensation for serving as an employee of AbbVie.
Shonda Foster Shonda Foster has received personal compensation for serving as an employee of Eli Lilly and Company. Shonda Foster has received stock or an ownership interest from Eli Lilly and Company.
Veronica Wangsadipura Veronica Wangsadipura has received personal compensation for serving as an employee of AbbVie. Veronica Wangsadipura has received stock or an ownership interest from AbbVie.
Matthew Campbell Matthew Campbell has nothing to disclose.
Diego Fernandez-Vial Linda Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Linda Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Sherie A. Dowsett Sherie A. Dowsett has received personal compensation for serving as an employee of Eli Lilly and Company. Sherie A. Dowsett has received stock or an ownership interest from Eli Lilly and Company.
Mason Daniel Dyess, DO Dr. Dyess has nothing to disclose.
Rashna Khanna Rashna Khanna has nothing to disclose.
Ashhar Ali, DO, FAAN Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Jonathan Rojo Jonathan Rojo has received personal compensation for serving as an employee of Allergan/Abbvie, Inc..
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Eugene Viscusi Eugene Viscusi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AcelRx. Eugene Viscusi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Innacoll. Eugene Viscusi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Heron. Eugene Viscusi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Salix. Eugene Viscusi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Esteve. Eugene Viscusi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fresenius. Eugene Viscusi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shinogi. Eugene Viscusi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Eugene Viscusi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Heron. Eugene Viscusi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Salix. Eugene Viscusi has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ASRA.
Juanzhi Fang Juanzhi Fang has received personal compensation for serving as an employee of Novartis Pharmaceutical. Juanzhi Fang has received stock or an ownership interest from Novartis Pharmaceutical.
Hsiangkuo Yuan, MD, PhD An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. The institution of Dr. Yuan has received research support from NIH. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Amr Shoukri Amr Shoukri has nothing to disclose.
Jordan Lateiner, MS, MBA Mr. Lateiner has received personal compensation for serving as an employee of Abbvie. Mr. Lateiner has received stock or an ownership interest from Abbvie.
Jennifer W. McVige, MD Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Noah Rosen, MD, FAAN Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen/ Novartis. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Headache Society.
Daniel Krashin, MD Dr. Krashin has nothing to disclose.
Cynthia A Brandt, 3859 The institution of Cynthia A Brandt, 3859 has received research support from Department of Veterans affairs.
Robert A. Nicholson, PhD Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Maurice Driessen Maurice Driessen has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Zenobia Dotiwala ZENOBIA DOTIWALA has nothing to disclose.
Joanne Kacperski, MD Dr. Kacperski has nothing to disclose.
Kelsey Satterly Kelsey Satterly has received personal compensation for serving as an employee of Impel NeuroPharma . Kelsey Satterly has received intellectual property interests from a discovery or technology relating to health care.
Deborah Freedman No disclosure on file
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Andreja Packard, MD, PhD Dr. Packard has nothing to disclose.
Narayan R. Kissoon, MD The institution of Dr. Kissoon has received research support from Nevro Corporation. Dr. Kissoon has received publishing royalties from a publication relating to health care.
Angie Graves Angie Graves has nothing to disclose.
Jessica Choudhry Jessica Choudhry has received personal compensation for serving as an employee of Amgen. Jessica Choudhry has received stock or an ownership interest from Amgen.
Fawad A. Khan, MD The institution of Dr. Khan has received research support from Amgen .
Florencia Wainberg, MD Dr. Wainberg has nothing to disclose.
Nico Pannacciulli Nico Pannacciulli has received personal compensation for serving as an employee of Amgen. Nico Pannacciulli has received stock or an ownership interest from Amgen.
Erin G. Doty, MD Dr. Doty has received personal compensation for serving as an employee of Eli Lilly and Company, USA. Dr. Doty has received stock or an ownership interest from Eli Lilly and Company, USA.
Ramiro Gabriel Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Tina Oakes Tina Oakes has received personal compensation for serving as an employee of Eli Lilly. Tina Oakes has received stock or an ownership interest from Eli Lilly.
Hasan Ashkanani Hasan Ashkanani has nothing to disclose.
Sunfa Cheng Sunfa Cheng has received personal compensation for serving as an employee of Amgen. Sunfa Cheng has received stock or an ownership interest from Amgen.
Morris Levin, MD, FAAN Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck. Dr. McAllister has stock in Percept.
Jan Lewis Brandes, MD Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Brandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lewis Thomason. Dr. Brandes has received research support from Amgen. Dr. Brandes has received research support from Teva. Dr. Brandes has received research support from Allergan. Dr. Brandes has received research support from Biohaven. Dr. Brandes has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
John H. Krege John H. Krege has received personal compensation for serving as an employee of Eli Lilly. John H. Krege has received stock or an ownership interest from Eli Lilly.
Holly Elser, MD, PhD Dr. Elser has nothing to disclose.
Joe Hirman, PhD Joe Hirman, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Joe Hirman, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel NeuroPharma.
Vivienne Shen Vivienne Shen has received personal compensation for serving as an employee of Lundbeck.
Martin Bog Martin Bøg has received personal compensation for serving as an employee of H Lundbeck A/S.
Richard Reimer No disclosure on file
Jack D. Schim, MD, FAAN Dr. Schim has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon, Abbvie, Amgen, Biohaven, electroCore, Impel, Lilly, Lundbeck, Novartis, Promius, Revance, Teva, Upsher-Smith. Dr. Schim has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, electroCore, Lilly, Lundbeck, Novartis, Promius, Teva, Theranica, Upsher-Smith.
Jonathan Stokes Jonathan Stokes has received personal compensation for serving as an employee of AbbVie. Jonathan Stokes has received stock or an ownership interest from AbbVie.
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Katherine Sommer Katherine Sommer has received personal compensation for serving as an employee of AbbVie. Katherine Sommer has stock in AbbVie.
Han Xiao Han Xiao has nothing to disclose.
Mallikarjuna Rettiganti, PhD Dr. Rettiganti has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Rettiganti has received stock or an ownership interest from Eli Lilly and Company.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Niushen Zhang, MD Dr. Zhang has nothing to disclose.
Joan Casey Joan Casey has nothing to disclose.
Andrew H. Ahn, MD, PhD Dr. Ahn has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Alicia Torborg Alicia Torborg has nothing to disclose.
Nitish Kumar, MD Dr. Kumar has nothing to disclose.
Lucia Mirea LUCIA MIREA has nothing to disclose.
Karen Craig Karen Craig has received personal compensation for serving as an employee of Impel NeuroPharma.
Mirja Koch Mirja Koch has received personal compensation for serving as an employee of Novartis.
Daniela Salvemini Daniela Salvemini has nothing to disclose.
Cynthia Emilie Armand, MD Dr. Armand has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spire Learning. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Tariq Hamid, MD Dr. Hamid has nothing to disclose.
Crystal Jicha, MD Dr. Jicha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LinPharma.
Brenda Fenton Brenda Fenton has nothing to disclose.
Alice Pressman No disclosure on file
Victor Fanjul Victor Fanjul has nothing to disclose.
Carrie Carr Carrie Carr has nothing to disclose.
Helen Hochstetler, PharmD Helen Hochstetler, PharmD has received personal compensation for serving as an employee of Eli Lilly and Company. Helen Hochstetler, PharmD has received stock or an ownership interest from Eli Lilly and Company.
Christopher Joseph Bondoc, MD Dr. Bondoc has nothing to disclose.
Brad C. Klein, MD, MBA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curax. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Impel. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biodelivery Science. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Spencer Seballos Spencer Seballos has nothing to disclose.
Sonja Bragg Sonja Bragg has received personal compensation for serving as an employee of eli lilly.
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Daniel Serrano, PhD Dr. Serrano has nothing to disclose.
Yongin Kim Yongin Kim has received personal compensation for serving as an employee of Eli Lilly and Company. Yongin Kim has received stock or an ownership interest from Eli Lilly and Company.
Antonia Periclou Antonia Periclou has received personal compensation for serving as an employee of Allergan/AbbVie. Antonia Periclou has received stock or an ownership interest from Allergan/AbbVie.
Veronica Astrid Moreno Gomez, MD Dr. Moreno Gomez has nothing to disclose.
Muhammad Affan, MD Dr. Affan has nothing to disclose.
Nicholas Gross, MS Nicholas Gross, MS has nothing to disclose.
Mary Hopkins Mary Hopkins has nothing to disclose.
Louise Lombard Louise Lombard has received personal compensation for serving as an employee of Eli Lilly.
Nasser Mohammed, MBBS Dr. Mohammed has nothing to disclose.
Scott Borland Scott Borland has received personal compensation for serving as an employee of Xoc Pharmaceuticals, Inc.. Scott Borland has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Xoc Pharmaceuticals, Inc.. Scott Borland has received stock or an ownership interest from Xoc Pharmaceuticals, Inc..
Charlie Conway Charlie Conway has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Charlie Conway has received stock or an ownership interest from Biohaven Pharmaceuticals.
Charles Iaconangelo, PhD Dr. Iaconangelo has received personal compensation for serving as an employee of Open Health Group.
Christina Sun-Edelstein, MD Dr. Sun-Edelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Sun-Edelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Sun-Edelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Sun-Edelstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Sun-Edelstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Sun-Edelstein has received publishing royalties from a publication relating to health care.
Tim P. Juergens An immediate family member of Tim P. Juergens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Tim P. Juergens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Tim P. Juergens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hormosan. The institution of Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Tim P. Juergens has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TEVA. Tim P. Juergens has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Tim P. Juergens has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Tim P. Juergens has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Tim P. Juergens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. The institution of Tim P. Juergens has received research support from GBA. The institution of Tim P. Juergens has received research support from EFRE. Tim P. Juergens has a non-compensated relationship as a President with German Headache and Migraine Society that is relevant to AAN interests or activities.
PUSHPA CHANDRASEKAR PUSHPA CHANDRASEKAR has received personal compensation for serving as an employee of AbbVie. PUSHPA CHANDRASEKAR has received stock or an ownership interest from AbbVie.
Frank R. Berenson, MD Dr. Berenson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Upsher smith. Dr. Berenson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Berenson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Berenson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Berenson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Berenson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Berenson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Atlanta Headache Specialists .
Jose H. Posas, MD, FAAN Dr. Posas has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie.
Paul B. Rizzoli, MD, FAAN Dr. Rizzoli has received personal compensation in the range of $0-$499 for serving as a Consultant for CVS. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Rizzoli has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publishing. The institution of Dr. Rizzoli has received research support from Abbvie. Dr. Rizzoli has received publishing royalties from a publication relating to health care.
Fayyaz Ahmed, MD, FRCP Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for allergan.
Cecilia Martindale Cecilia Martindale has nothing to disclose.
Erika Liktor-Busa Erika Liktor-Busa has nothing to disclose.
Melissa Skanderson Melissa Skanderson has nothing to disclose.
YASHAR ESHRAGHI YASHAR ESHRAGHI has nothing to disclose.
Catherine Daniela Chong, PhD, FAAN Dr. Chong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCOP. The institution of Dr. Chong has received research support from AMGEN. The institution of Dr. Chong has received research support from Department of Defense. The institution of Dr. Chong has received research support from NIH. An immediate family member of Dr. Chong has received intellectual property interests from a discovery or technology relating to health care.
Shawn Michael Ferger, RN Mr. Ferger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. Mr. Ferger has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan Pharmaceuticals.
Bill Prucka Bill Prucka has received personal compensation for serving as an employee of Eli Lilly and Company. Bill Prucka has stock in Eli Lilly and Company.
Anders Lassen Anders Lassen has received personal compensation for serving as an employee of Lundbeck. Anders Lassen has received stock or an ownership interest from Lundbeck.
Kory Schuh, 15302 Kory Schuh has received personal compensation for serving as an employee of Eli Lilly and Company.
Susan LeCates Susan LeCates has nothing to disclose.
Poonam Bansal, MD Dr. Bansal has nothing to disclose.
Pamela Vo, PharmD, MS Pamela Vo has received stock or an ownership interest from Novartis.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Yohannes W. Woldeamanuel, MD Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Research Square. The institution of Dr. Woldeamanuel has received research support from NINDS.
Abinayaa Ravichandran Abinayaa Ravichandran has nothing to disclose.
Faisal Abdelaziz Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Tejas R. Mehta, MD Dr. Mehta has nothing to disclose.
Anders Ettrup Anders Ettrup has received personal compensation for serving as an employee of H. Lundbeck A/S.
Kendra K. Davis Ms. Davis has nothing to disclose.
Ankita Ghosh, MD Dr. Ghosh has nothing to disclose.
Monica Prasad Mallampalli, PhD Monica Mallampalli has nothing to disclose.
Ahmad Abdrabboh, PharmD Ahmad Abdrabboh, PharmD has received personal compensation for serving as an employee of Novartis. Ahmad Abdrabboh, PharmD has received stock or an ownership interest from Novartis.
Anusha Badveli, DM Dr. Badveli has nothing to disclose.
Uwe Reuter Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Liily Deutschland. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape . Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for StreaMEdUp. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Reuter has received research support from Novartis.
Sawsan Alwazzan No disclosure on file
Miguel Guzman Miguel Guzman has received personal compensation for serving as an employee of Xoc Pharmaceuticals. Miguel Guzman has received stock or an ownership interest from Xoc Pharmaceuticals. Miguel Guzman has received personal compensation in the range of $100,000-$499,999 for serving as a VP, Product Development with Xoc Pharmaceuticals.
Gary D. Berman, MD Dr. Berman has received personal compensation for serving as an employee of Clinical Research Institute. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Lisa Borbridge Lisa Borbridge has received personal compensation for serving as an employee of AbbVie. Lisa Borbridge has received stock or an ownership interest from AbbVie.
Niranjan N. Singh, MD, FAAN Dr. Singh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Brian Grosberg, MD Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Austin L. Hand Austin L. Hand has received personal compensation for serving as an employee of IQVIA. Austin L. Hand has received personal compensation for serving as an employee of Corcept Therapeutics .
Kathleen B. Digre, MD, FAAN Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Brian Koo, MD Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Claudia Varela Claudia Varela has nothing to disclose.
Ami Zarrillo Cuneo, MD Dr. Cuneo has nothing to disclose.
Paula M. Hauck Paula M Hauck has received personal compensation for serving as an employee of Eli Lilly and Company.
Xiaoping Ning Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Michael Seminerio Michael Seminerio has received personal compensation for serving as an employee of AbbVie.
Verena *use 212969 Ramirez Campos Verena Ramirez Campos has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Cassandra Recchioni Cassandra Recchioni has nothing to disclose.
Chien-Cheng Chen Chien-Cheng Chen has received personal compensation for serving as an employee of StatInMed.
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Ammar Tarabichi, MD Dr. Tarabichi has nothing to disclose.
Kathryn H. Keller, PharmD Kathryn H. Keller, PharmD has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Kathryn H. Keller, PharmD has received stock or an ownership interest from Biohaven Pharmaceuticals.
Annika Ehrlich, NP Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Ms. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Ms. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Meditation teacher with Miles for Migraine. Ms. Ehrlich has a non-compensated relationship as a Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities. Ms. Ehrlich has a non-compensated relationship as a Board member with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Ms. Ehrlich has a non-compensated relationship as a Medical reviewer (volunteer) with Migraine Again that is relevant to AAN interests or activities.
Liqi Shu, MD Dr. Shu has nothing to disclose.
Andrew D. Hershey, MD, PhD, FAHS, FAAN The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Alice Jacobson Alice Jacobson has nothing to disclose.
Farhan *use130785 Siddiq Farhan Siddiq has nothing to disclose.
Julie Roth, MD, FAAN Dr. Roth has nothing to disclose.
Stephen F. Thompson Stephen Thompson has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Carrie Dougherty, MD Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Dougherty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dougherty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Dougherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Dougherty has received personal compensation in the range of $0-$499 for serving as a Consultant for Relivion. The institution of Dr. Dougherty has received research support from Eli Lilly and Co. The institution of Dr. Dougherty has received research support from AbbVie. The institution of Dr. Dougherty has received research support from Axsome.
Lujia Zhou Lujia Zhou has received personal compensation for serving as an employee of KMK Consulting, Inc.
Maja *use 301657 Galic No disclosure on file
Kelly Karlage Kelly Karlage has nothing to disclose.
Alexandra Thiry Alexandra Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Alexandra Thiry has received stock or an ownership interest from Biohaven Pharmaceuticals.
Sachin M. Bhagavan, MD Dr. Bhagavan has nothing to disclose.
Amy Grinberg, PhD The institution of Amy Grinberg has received research support from Department of Veteran Affairs.
Leah Kleinman Leah Kleinman has received personal compensation for serving as an employee of Evidera.
Elizabeth Seng, PhD Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. The institution of Dr. Seng has received research support from NINDS.
Hema Viswanathan Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Krishna Tangirala Krishna Tangirala has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Patricia Pozo-Rosich, MD, PhD Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Foundation Spain. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Andre White Andre White has a non-compensated relationship as a contributing scientist and Director with XTAL BioStructures that is relevant to AAN interests or activities.
Kira Misura Kira Misura has received personal compensation for serving as an employee of Lundbeck Seattle Biopharmaceuticals. Kira Misura has received personal compensation for serving as an employee of Alder Biopharmaceuticals. Kira Misura has received stock or an ownership interest from Alder Biopharmaceuticals.
Jason J. Sico, MD, FAAN Dr. Sico has nothing to disclose.
Abraham *use 112134 Nagy Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zosano. Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Electrocore. Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Abraham Nagy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder. The institution of Abraham Nagy has received research support from Amgen/Novartis. The institution of Abraham Nagy has received research support from Lilly. The institution of Abraham Nagy has received research support from Teva pharmaceuticals. The institution of Abraham Nagy has received research support from Allergan. The institution of Abraham Nagy has received research support from Zosano. The institution of Abraham Nagy has received research support from Alder Pharmaceuticals.
Samar Farouk Ahmed, MD Dr. Ahmed has nothing to disclose.
Yoshimi Hisamoto, MD Dr. Hisamoto has nothing to disclose.
Harsh Dandona Harsh Dandona has nothing to disclose.
Carmen Ramos Carmen Ramos has nothing to disclose.
Philip Cyr Philip Cyr has received personal compensation for serving as an employee of PRECISIONheor.
Rashmi B. Halker Singh, MD, FAAN Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Mika Komori Mika Komori has received personal compensation for serving as an employee of Eli Lilly K.K..
Mario F. P. Peres, MD Dr. Peres has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eurofarma. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Libbs. Dr. Peres has received research support from CNPq. Dr. Peres has received research support from Allergan.
Paola Valsasina Paola Valsasina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACCMED.
Raghavendra Vasudeva, PhD Dr. Vasudeva has received personal compensation for serving as an employee of Lilly. Dr. Vasudeva has received stock or an ownership interest from Lilly.
Stephanie Bariahtaris Stephanie Bariahtaris has received personal compensation for serving as an employee of Impel NeuroPharma. Stephanie Bariahtaris has received stock or an ownership interest from Impel NeuroPharma.
Rebecca Hogan Rebecca Hogan has nothing to disclose.
Charly Gaul, MD Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hormosan. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gruenenthal. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Perfood. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Weber & Weber.
Joshua *use 125685 Cohen Joshua Cohen has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Qun Lin Qun Lin has received personal compensation for serving as an employee of Eli Lilly and Company. Qun Lin has received stock or an ownership interest from Eli Lilly and company .
Rogelio Dominguez-Moreno, MD Dr. Dominguez-Moreno has received publishing royalties from a publication relating to health care.
Wojciech Gryc, MD Dr. Gryc has nothing to disclose.
Nicole Kellier-Steele Nicole Kellier-Steele has received personal compensation for serving as an employee of Eli Lilly and Company. Nicole Kellier-Steele has received stock or an ownership interest from Eli Lilly and Company.
Sarah Molly Bobker, MD Dr. Bobker has nothing to disclose.
Aidan Levine Mr. Levine has received research support from University of Arizona MD/PhD Program.
Robert Cowan, MD, FAAN Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Stephen Bevan Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Lahar R. Mehta, MD Dr. Mehta has received personal compensation for serving as an employee of Amylyx Pharmaceuticals.
Juan Ignacio Castiglione, MD Dr. Castiglione has nothing to disclose.
Jennifer R. Cheng, NP Ms. Cheng has nothing to disclose.
Sanjay Gandhi, MD Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Robert A. Duarte, MD Dr. Duarte has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LILLY . Dr. Duarte has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan . Dr. Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY . Dr. Duarte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LILLY . Dr. Duarte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Duarte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Duarte has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HPMB.
Jackie Yang Jackie Yang has nothing to disclose.
Ye Li Ye Li has received personal compensation for serving as an employee of AbbVie.
Paul Winner, DO, FAAN Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Ana Beatriz Gago Veiga Ana Beatriz Gago Veiga has nothing to disclose.
Sara Habib, MD, MBBS Dr. Habib has nothing to disclose.
Fan Mu, PhD Fan Mu, PhD has nothing to disclose.
Luigino Antonio Giancotti Luigino Antonio Giancotti has nothing to disclose.
Brian Baker Brian Baker has received personal compensation for serving as an employee of Lundbeck Seattle BioPharmaceuticals. Brian Baker has received stock or an ownership interest from Alder BioPharmaceuticals.
Beth Morris Beth Morris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Beth Morris has received stock or an ownership interest from Biohaven Pharmaceuticals Inc.
Karissa Johnston Karissa Johnston has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Max Myers Max Myers has nothing to disclose.
Tamar Lin Tamar Lin has received personal compensation for serving as an employee of Theranica Bio-Electronics.
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Russell Nichols Russell Nichols has received personal compensation for serving as an employee of Eli Lilly and Company. Russell Nichols has received stock or an ownership interest from Eli Lilly and Company.
John *use 387100 Hoekman John Hoekman has received personal compensation for serving as an employee of Impel Neuropharma. John Hoekman has received stock or an ownership interest from Impel Neuropharma. John Hoekman has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Esmael No disclosure on file
Monique Maria Montenegro, MD Dr. Montenegro has nothing to disclose.
Larisa Yedigarova Larisa Yedigarova has received personal compensation for serving as an employee of AbbVie. Larisa Yedigarova has received stock or an ownership interest from AbbVie.
Merrill Maguire Brady Moe, MD Dr. Brady has nothing to disclose.
Linda Wietecha, RN, MS Ms. Wietecha has received personal compensation for serving as an employee of Eli Lilly and Company. Ms. Wietecha has received stock or an ownership interest from Eli Lilly and Company.
Leonard Shou, DO Dr. Shou has nothing to disclose.
Egilius L H Spierings, MD,PhD Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manistee. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Marissa Baker-Wagner Marissa Baker-Wagner has nothing to disclose.
Monika Maier Peuschel Monika Maier Peuschel has received personal compensation for serving as an employee of Novartis Pharma . Monika Maier Peuschel has received stock or an ownership interest from Novartis Pharma AG.
Richard Kovacs Richard Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Richard Kovacs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cook Research Inc. Richard Kovacs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prilenia. Richard Kovacs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University Southern California. Richard Kovacs has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for American College of Cardiology. The institution of Richard Kovacs has received research support from NHLBI.
Feng *Use 393271 Zhang Feng Zhang has received personal compensation for serving as an employee of Amgen Inc.
Erafat Rehim, MD Dr. Rehim has nothing to disclose.
Almudena Villa Almudena Villa has nothing to disclose.
Dulanji Kuruppu, MD Dr. Kuruppu has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Kuruppu has received stock or an ownership interest from Eli Lilly and Company.
Bruno Colombo Bruno Colombo has nothing to disclose.
Andrea Olland Andrea Olland has a non-compensated relationship as a author on a submitted abstract with Alder Bio (now Lundberg) that is relevant to AAN interests or activities.
Gabriella O'Fallon Ms. O'Fallon has nothing to disclose.
Scott Powers, PhD Scott Powers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. The institution of Scott Powers, PhD has received research support from NIH. The institution of Scott Powers, PhD has received research support from PCORI. Scott Powers, PhD has a non-compensated relationship as a Associate Editor with The Journal HEADACHE that is relevant to AAN interests or activities. Scott Powers, PhD has a non-compensated relationship as a Member Board of Directors with American Headache Society that is relevant to AAN interests or activities.
Kathryn Min Kathryn Min has nothing to disclose.
Sara Ephross Sara Ephross has received personal compensation for serving as an employee of Syneos Health. Sara Ephross has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for INC Research/Syneos Health. Sara Ephross has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for GlaxoSmithKline. Sara Ephross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ohana Bioscience.
Andrew Buchanan No disclosure on file
Roberta Messina, MD, PhD Dr. Messina has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Messina has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly.
Visar Berisha Visar Berisha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Visar Berisha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Visar Berisha has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Aural Analytics. Visar Berisha has received stock or an ownership interest from Aural Analytics. The institution of Visar Berisha has received research support from Boheringer Ingelheim. Visar Berisha has received intellectual property interests from a discovery or technology relating to health care.
Jorge Serrano Jorge Serrano has nothing to disclose.
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Marmura has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Marmura has stock in Curelator. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Donald Kellerman No disclosure on file
Nada A. Hindiyeh, MD Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck .
Robert Fishman, MD Dr. Fishman has nothing to disclose.
Mary Haywood Mary Haywood has nothing to disclose.
Thomas Brevig Thomas Brevig has received personal compensation for serving as an employee of H. Lundbeck A/S. Thomas Brevig has received personal compensation for serving as an employee of Gedeon Richter Plc.. Thomas Brevig has stock in H. Lundbeck A/S.
Thibaud Prawitz Thibaud Prawitz has received personal compensation for serving as an employee of Evidera.
Maria Jeleva Maria Jeleva has received personal compensation for serving as an employee of Impel NeuroPharma.
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Megan Rooney Megan Rooney has nothing to disclose.
Abraham J. Nagy, MD No disclosure on file
Diane Whalley Diane Whalley has received personal compensation for serving as an employee of RTI Health Solutions.